PubRank

S G Reed

Author PubWeight™ 188.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 1992 3.71
2 Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 1998 3.55
3 Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 1985 3.41
4 Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A 1993 3.40
5 Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992 3.34
6 Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993 3.28
7 rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis 1996 2.93
8 New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986 2.92
9 Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med 1991 2.68
10 Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J Parasitol 1995 2.37
11 Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med 1989 2.30
12 Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994 2.25
13 CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996 2.11
14 Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J Exp Med 1998 2.06
15 Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000 1.98
16 Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect Immun 1999 1.95
17 Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 1986 1.93
18 Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 1996 1.93
19 rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol 1998 1.90
20 Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 1987 1.87
21 P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001 1.86
22 Murine thymocytes proliferate in direct response to interleukin-7. Blood 1989 1.86
23 A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J Exp Med 1995 1.81
24 T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol 2000 1.76
25 Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci U S A 1993 1.76
26 IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol 1995 1.69
27 Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells. Mol Diagn 2001 1.67
28 Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol 2000 1.66
29 Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol 1984 1.65
30 Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells. J Exp Med 2000 1.60
31 Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. Infect Immun 1999 1.55
32 Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case report. Braz J Infect Dis 2001 1.54
33 Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity. J Immunol 2001 1.54
34 Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infect Immun 1998 1.53
35 Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect Immun 2001 1.51
36 Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000 1.51
37 Regulation of T cell proliferation by IL-7. J Immunol 1990 1.50
38 IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 1994 1.46
39 Suppressed antibody responses to sheep erythrocytes in mice with chronic Trypanosoma cruzi infections are restored with interleukin 2. J Immunol 1984 1.45
40 Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J Clin Microbiol 2000 1.44
41 A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. J Infect Dis 1998 1.43
42 Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997 1.43
43 Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis. J Immunol 1998 1.38
44 Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol Biochem Parasitol 1999 1.38
45 Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy. Am J Trop Med Hyg 1990 1.37
46 Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients. J Exp Med 1992 1.37
47 Heterologous antibody responses in mice with chronic T. cruzi infection: depressed T helper function restored with supernatants containing interleukin 2. J Immunol 1984 1.35
48 Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi. Proc Natl Acad Sci U S A 1992 1.34
49 Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. Am J Trop Med Hyg 1983 1.32
50 Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera. J Immunol 1987 1.32
51 Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction. J Immunol 2000 1.31
52 LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J Immunol 1998 1.31
53 Suppression of cell-mediated immunity in experimental Chagas' disease. Z Parasitenkd 1977 1.30
54 Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis. Infect Immun 1998 1.28
55 Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin. Trans R Soc Trop Med Hyg 1995 1.27
56 A multi-epitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in radioimmunoprecipitation-confirmed and consensus-positive sera. J Infect Dis 1999 1.25
57 Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice. Infect Immun 2002 1.25
58 Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J Immunol 1996 1.24
59 Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses. Am J Trop Med Hyg 1986 1.24
60 Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Infect Immun 1995 1.20
61 Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J Immunol 1998 1.19
62 Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice. J Immunol 1983 1.18
63 Molecular karyotype of species and subspecies of Leishmania. Mol Biochem Parasitol 1986 1.17
64 Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol 2001 1.16
65 Serological expression cloning and immunological evaluation of MTB48, a novel Mycobacterium tuberculosis antigen. J Clin Microbiol 2001 1.15
66 Antibody responses of visceral leishmaniasis patients to gp63, a major surface glycoprotein of Leishmania species. J Infect Dis 1993 1.15
67 Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunol 1995 1.15
68 Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. Oncogene 2000 1.14
69 Identification and characterization of prostein, a novel prostate-specific protein. Cancer Res 2001 1.12
70 Human T cell responses to gp63, a surface antigen of Leishmania. J Immunol 1991 1.12
71 Leishmania gp63 molecule implicated in cellular adhesion lacks an Arg-Gly-Asp sequence. Mol Biochem Parasitol 1990 1.10
72 Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. J Clin Microbiol 2001 1.10
73 Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J Immunol 1991 1.09
74 Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol 1991 1.09
75 Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides. J Clin Microbiol 2001 1.09
76 Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens. J Clin Microbiol 1994 1.08
77 Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J Immunol 2001 1.07
78 A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur J Immunol 1997 1.06
79 Treatment of experimental visceral leishmaniasis with lymphokine encapsulated in liposomes. J Immunol 1984 1.05
80 Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J Exp Med 1995 1.04
81 Adjuvants for malaria vaccines. Parasite Immunol 2009 1.04
82 TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J Immunol 1995 1.03
83 Antigen-reactive gamma delta T cells in human leishmaniasis. J Immunol 1993 1.01
84 Serological expression cloning of novel immunoreactive antigens of Babesia microti. Infect Immun 2000 1.01
85 Trypanosoma cruzi acidic ribosomal P protein gene family. Novel P proteins encoding unusual cross-reactive epitopes. J Immunol 1993 0.99
86 Contact sensitivity responses in mice infected with Trypanosoma cruzi. Infect Immun 1978 0.99
87 Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopes. J Immunol 1993 0.99
88 Multiepitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas' disease. J Infect Dis 2000 0.99
89 L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br J Cancer 2003 0.98
90 Characterization of a Leishmania tropica antigen that detects immune responses in Desert Storm viscerotropic leishmaniasis patients. Proc Natl Acad Sci U S A 1995 0.98
91 Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J Immunol 1992 0.98
92 Detection of mammaglobin in the sera of patients with breast cancer. Tumour Biol 2002 0.98
93 Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins. Infect Immun 1994 0.97
94 Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity. J Infect Dis 2000 0.96
95 Molecular characterization of the heat-inducible LmSTI1 protein of Leishmania major. Mol Biochem Parasitol 1997 0.96
96 Visceral leishmaniasis in a new ecological niche near a major metropolitan area of Brazil. Trans R Soc Trop Med Hyg 1995 0.95
97 A polymorphic multigene family encoding an immunodominant protein from Babesia microti. J Clin Microbiol 2000 0.95
98 Chagas disease in Ecuador: evidence for disease transmission in an Indigenous population in the Amazon region. Mem Inst Oswaldo Cruz 1998 0.95
99 Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections. Am J Trop Med Hyg 1993 0.94
100 Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis. J Infect Dis 1990 0.94
101 Diminished in vitro production of interleukin-1 and tumor necrosis factor-alpha during acute visceral leishmaniasis and recovery after therapy. J Infect Dis 1992 0.94
102 Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis. Clin Microbiol Infect 2013 0.94
103 Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India. Clin Microbiol Infect 2011 0.93
104 Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am J Trop Med Hyg 1998 0.92
105 A rapid and simple diagnostic test for active visceral leishmaniasis. Am J Trop Med Hyg 1991 0.91
106 Interleukin-3 induces antimicrobial activity against Leishmania amazonensis and Trypanosoma cruzi and tumoricidal activity in human peripheral blood-derived macrophages. Infect Immun 1992 0.90
107 Cross reactivity between Trypanosoma cruzi and Leishmania antigens in the lymphocyte blastogenesis assay. Trans R Soc Trop Med Hyg 1987 0.90
108 Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. J Infect Dis 1994 0.90
109 Human T-cell responses in Leishmania infections. Prog Clin Parasitol 1993 0.90
110 Characterization of responses of normal human T cells to Trypanosoma cruzi antigens. J Immunol 1993 0.90
111 Trypanosoma cruzi meningoencephalitis in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1999 0.88
112 Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes. Clin Exp Immunol 1987 0.87
113 Prevalence of cutaneous leishmaniasis along the Nile River north of Khartoum (Sudan) in the aftermath of an epidemic in 1985. Am J Trop Med Hyg 1993 0.87
114 Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers. Eur J Clin Microbiol Infect Dis 2011 0.87
115 Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. J Immunol 1993 0.87
116 Adoptive transfer of resistance to acute Trypanosoma cruzi infection with T-lymphocyte-enriched spleen cells. Infect Immun 1980 0.87
117 Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux test. Tuberculosis (Edinb) 2001 0.86
118 Granulocyte/macrophage colony stimulating factor. A potent activation signal for mature macrophages and monocytes. Int Arch Allergy Appl Immunol 1989 0.86
119 Longitudinal evaluation of sealing molars with and without incipient dental caries in a public health program. J Public Health Dent 1995 0.86
120 Potent stimulation of the innate immune system by a Leishmania brasiliensis recombinant protein. Infect Immun 2001 0.86
121 Sensitivity and specificity of a recombinant Leishmania chagasi antigen in the serodiagnosis of visceral leishmaniasis. Arch Inst Pasteur Tunis 1995 0.85
122 Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis. Eur J Clin Microbiol Infect Dis 2014 0.84
123 Molecular cloning and characterization of a 42-kDa protein phosphatase of Leishmania chagasi. J Biol Chem 1993 0.84
124 Effect of cortisone and cyclophosphamide on the immunological role of BCG in Balb/c mice challenged with Leishmania donovani. Am J Trop Med Hyg 1980 0.84
125 Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy. Eur J Clin Microbiol Infect Dis 2011 0.84
126 Association of Leishmania heat shock protein 83 antigen and immunoglobulin G4 antibody titers in Brazilian patients with diffuse cutaneous leishmaniasis. Infect Immun 1997 0.83
127 L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma. Oncogene 2001 0.82
128 Cytokines in the treatment of leishmaniasis: from studies of immunopathology to patient therapy. Biotherapy 1994 0.82
129 Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment. Eur J Clin Microbiol Infect Dis 2013 0.81
130 Rapid screening with a recombinant antigen (rK39) for diagnosis of visceral leishmaniasis using dipstick. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2000 0.80
131 Leishmania mexicana amazonensis infections in 'resistant' inbred mice following removal of the draining lymph node. Clin Exp Immunol 1986 0.80
132 Effect of visceral leishmaniasis on congenitally athymic mice. Infect Immun 1979 0.80
133 Molecular cloning and characterization of two iron superoxide dismutase cDNAs from Trypanosoma cruzi. Mol Biochem Parasitol 1997 0.80
134 Factors associated with gingival inflammation among adults with systemic sclerosis. Int J Dent Hyg 2013 0.79
135 Surface interactions between macrophages and Trypanosoma cruzi. Am J Trop Med Hyg 1982 0.78
136 Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells. J Infect Dis 1996 0.78
137 Evaluation of a synthetic tripeptide as antigen for detection of IgM and IgG antibodies to Trypanosoma cruzi in serum samples from patients with Chagas disease or viral diseases. Trans R Soc Trop Med Hyg 2000 0.78
138 The pathology of experimental visceral leishmaniasis in resistant and susceptible lines of inbred mice. Braz J Med Biol Res 1987 0.78
139 Mapping human T cell epitopes in Leishmania gp63: identification of cross-reactive and species-specific epitopes. J Immunol 1993 0.78
140 Evaluation of the stability of a soluble intradermal skin test antigen preparation in American visceral leishmaniasis. Trans R Soc Trop Med Hyg 1990 0.78
141 Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy. Eur J Clin Microbiol Infect Dis 2014 0.78
142 Destruction of Leishmania mexicana amazonensis promastigotes by normal human serum. Am J Trop Med Hyg 1987 0.77
143 Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis. Eur J Clin Microbiol Infect Dis 1994 0.77
144 Leishmaniasis vaccination: targeting the source of infection. J Exp Med 2001 0.76
145 Immune responses to T-dependent and T-independent antigens during visceral leishmaniasis in mice: evidence for altered T-cell regulation of immune responses to non-parasite antigens. Cell Immunol 1985 0.75
146 A p53 homologue and a novel serine proteinase inhibitor are over-expressed in lung squamous cell carcinoma. Lung Cancer 2001 0.75
147 Chemical deglycosylation can induce methylation, succinimide formation, and isomerization. J Protein Chem 2001 0.75